Hologic's Surgical business has been recording strong broad-based performance by expanding access to technologies into new global markets. Examine the evolution of Hologic's (HOLX) overseas ...

After hours: February 14 at 6:42:49 PM EST Loading Chart for HOLX ...

Leerink Partners analyst Puneet Souda maintained a Buy rating on Hologic (HOLX – Research Report ... for mammography and minimally invasive breast biopsy devices, breast biopsy site markers ...

Liquid biopsy is emerging as a less invasive method for cancer detection and monitoring. High adoption rates are seen in oncology and prenatal diagnostics. Liquid Biopsy Tube Market growth was ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

(RTTNews) - While reporting its results for the first quarter, Hologic, Inc. (HOLX) revised its outlook for the full year 2025. Looking forward to the full year 2025, the company now expects ...

Raymond James lowered the firm’s price target on Hologic (HOLX) to $90 from $95 and keeps an Outperform rating on the shares. Hologic’s print was essentially in line, but revenue guidance was ...

5 S&P 500 Stocks Set To Shine In The Final Week Of January — If History Repeats Itself S&P 500 surges to record highs in final week of January as investors react to economic optimism, Trump's ...

Find out what happened in the markets today – and why you should care – with the free Daily Brief newsletter. Hologic's fiscal 2025 revenue outlook is under scrutiny after a decline in its breast ...